American Cannabis Company Inc (OTCMKTS:AMMJ) has announced that it has signed up a new client, in Pennsylvania, which is planning to apply for the medical marijuana program, about to be introduced in the state. The company voiced its belief that the project would bring revenues, for a large period of time. This could be possible if the client decides to sign consulting agreements with AMMJ, receive aid in cultivation operations or buys additional ancillary products.

The CEO of American Cannabis, Corey Hollister, pointed out that Pennsylvania is one of the major markets for marijuana products, given that it is the 6^th most populated US state. He revealed that the new client has a proven track record of success in other sectors, which would serve as the key to their success in medical marijuana as well. It should be noted here that this is the second contract, in less than a month, for the company.

Earlier in October, AMMJ had announced the signing of a design and consulting agreement, with a Canadian firm, to create a licensed cannabis producer facility. Although the firm was yet to receive its license from the concerned authorities, American Cannabis has already begun the planning phase of the project. The company stated that the project would have multiple phases.

The initial phase involves the construction of the indoor facility, but operations would not start until the license has been received. Until such time, the firm plans to cultivate an alternative crop, with a transition plan in place. In addition to this, the firm also plans to expand the facility, through the creation of greenhouses and indoor expansion. Mr. Hollister commented on the agreement, claiming that the Canadian market is growing at an accelerated pace and their new client is well positioned to excel in this market. He further revealed that the firm has successful business operations in Canada and in the international market as well.

American Cannabis Company Inc (OTCMKTS:AMMJ) had a trade volume of 3.22 million and lost 17.07% of its share value, during the November 9 trading session, to close at $1.36 per share.